Retatrutide is the injectable triple agonist that hits GLP-1, GIP, and glucagon receptors at once, and it reached up to 24.2 percent average body weight loss in its Phase 2 obesity trial
NAC is more affordable, better studied in clinical trials, and raises intracellular glutathione reliably at doses of 6001200mg twice daily
The practical takeaway is that L-carnitine may support a weight-management program, but it should be paired with exercise, adequate protein intake and an energy-controlled diet
Common side effects include nausea, constipation, and appetite reductionoften mild and transient
What are the main risks of taking GLP-1 medications after cholecystectomy
Cell and Tissue Research, 377(2), 153-159